Medigene AG buy MoneyMoney
Start price
09.04.18
/
50%
€14.12
Target price
18.11.19
€20.00
Performance (%)
-58.75%
End price
18.11.19
€5.83
Summary
This prediction ended on 18.11.19 with a price of €5.83. Massive losses of -58.75% were the result for the BUY prediction by MoneyMoney. MoneyMoney has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Medigene AG | 2.303% | 2.303% | -8.529% | -62.165% |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% | 16.075% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% | 46.938% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% | 4.643% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% | 42.418% |
According to MoneyMoney what are the pros and cons of Medigene AG for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Significant cyclical dependencies
Comments by MoneyMoney for this prediction
In the thread Medigene AG diskutieren
Medigene NA
Die Aktie ist von ihrem Hoch Anfang des Jahres von 19 € auf fast 14 - 14,50 gefallen.
Auch die präsentierten Zahlen waren nicht wirklich gut.
Dies hängt natürlich auch mit den gestiegenen Forschungskosten zusammen.
Trotzdem glaube ich , dass die Aktie mittel - bis langfristig Chancen aufweist .
Stopped prediction by MoneyMoney for Medigene AG
Medigene AG
Start price
Target price
Perf. (%)
€3.79
22.02.22
22.02.22
€4.00
22.02.23
22.02.23
-45.05%
23.02.23
23.02.23
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Medigene AG
Start price
Target price
Perf. (%)
€13.67
05.09.17
05.09.17
€17.00
24.01.18
24.01.18
25.09%
24.01.18
24.01.18
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Medigene AG
Start price
Target price
Perf. (%)
€8.96
10.01.16
10.01.16
€13.00
28.12.16
28.12.16
33.93%
28.12.16
28.12.16
Could be worthwhile Investment >10% per year
Significant cyclical dependencies